Y-Biologics Major Shareholder Park Young-woo's Stake Slightly Drops to 30.28% Due to Related Party's Stock Option Exercise
Y-Biologics major shareholder Park Young-woo reported a change in holding form due to the exercise of 60,000 stock options by related party Jang Woo-ik on April 9, 2026.
As a result, total outstanding shares increased to 15,366,681, and the combined ownership of Park and his special relations decreased from 30.66% to 30.28%, a drop of 0.38 percentage points.
The exercise price was 9,767 KRW per share, and total acquisition funds amounted to 586,020,000 KRW, of which 100,000,000 KRW was borrowed.
This is an existing option exercise, not a new capital raise or convertible bond issuance, resulting in negligible dilution for existing shareholders.
[AI Summary]The change in Y-Biologics major shareholder's stake is a technical adjustment due to a small-scale stock option exercise by a related party, involving no change in management control or capital structure. Therefore, its impact on short-term stock price is limited and investment risk is low.